BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4339425)

  • 1. Inhibition of chemical carcinogenesis by viral vaccines.
    Whitmire CE; Huebner RJ
    Science; 1972 Jul; 177(4043):60-1. PubMed ID: 4339425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Rauscher leukemia virus vaccine upon chemical oncogenesis in the mouse.
    Basombrío MA; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(8):630-3. PubMed ID: 1021012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice.
    Kelloff GJ; Peters RL; Donahoe RM; Ghazzouli I; Sass B; Nims RM; Huebner RJ
    Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-chemical carcinogenesis: a possible viral immunologic influence on 3-methylcholanthrene sarcoma induction.
    Whitmire CE
    J Natl Cancer Inst; 1973 Aug; 51(2):473-8. PubMed ID: 4358133
    [No Abstract]   [Full Text] [Related]  

  • 6. RNA tumor virus genomes as determinants of chemically-induced transformation in vitro.
    Freeman AE; Price PJ; Zimmerman EM; Kelloff GJ; Huebner RJ
    Bibl Haematol; 1973; 39():617-34. PubMed ID: 4360186
    [No Abstract]   [Full Text] [Related]  

  • 7. RNA tumor virus antigen expression in chemically-induced tumors. Significance of specific chemical carcinogens to the derepression of the C-type RNA virogene and oncogene expressions.
    Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ
    Bibl Haematol; 1973; 39():574-88. PubMed ID: 4360184
    [No Abstract]   [Full Text] [Related]  

  • 8. [An immunohistochemical study of the group specific antigen of mouse leukemia viruses].
    Lezhneva OM; Abelev GI
    Vopr Virusol; 1971; 16(3):348-53. PubMed ID: 4332918
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic control of susceptibility to 3-methylcholanthrene-induced subcutaneous sarcomas.
    Kouri RE; Ratrie H; Whitmire CE
    Int J Cancer; 1974 May; 13(5):714-20. PubMed ID: 4135774
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical co-carcinogenesis: differential action of various compounds, derepression of endogenous C-type RNA genomes, and influence of different genotypes of mice.
    Meier H; Myers DD
    Bibl Haematol; 1973; 39():551-73. PubMed ID: 4360183
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of endogenous type-C virus in normal hamster tissues and hamster tumors induced by chemical carcinogens, simian virus 40, and polyoma virus.
    Freeman AE; Kelloff GJ; Vernon ML; Lane WT; Capps WI; Bumgarner SD; Turner HC; Huebner RJ
    J Natl Cancer Inst; 1974 May; 52(5):1469-76. PubMed ID: 4364732
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
    J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 15. RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.
    Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC
    J Natl Cancer Inst; 1971 Dec; 47(6):1255-65. PubMed ID: 4330465
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay in the mouse for delayed-type hypersensitivity to murine leukemia virus.
    Peters RL; Donahoe RM; Kelloff GJ
    J Natl Cancer Inst; 1975 Nov; 55(5):1089-95. PubMed ID: 54434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice.
    Meier H; Taylor BA; Cherry M; Buebner RJ
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1450-5. PubMed ID: 4351180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subcutaneous administration of chemical carcinogens on leukemia in C58 mice.
    Whitmire CE
    J Natl Cancer Inst; 1979 Mar; 62(3):555-9. PubMed ID: 216841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.